Talecris Biotherapeutics (TLCR)

Latest Trade: $22.55 0.00 (0.0%)

IPO News

Latest User Comments

Post Comment | Read More

Business

Business
Former Bayer maker of plasma-derived protein therapies LBO'd by Cerberus.
Industry
Health-Drugs
Employees
3472
Founded
1995

Performance History

Invest in the IPO Plus Fund

First Day Return
21.1500

11.3%
Aftermarket Return
21.1500

6.6%
Return from IPO
19.0000

18.7%

IPO Date
09/30/09
Offer Price
$19.00
Offer Shares
50.0 mm
Lead Manager(s)
Morgan Stanley
Goldman Sachs
Citi

All Underwriters

TLCR Daily

Week

Month

Quarter

1 Year

Basic
Comps

Financial Data* ($ in millions)

Market Cap
$2,899.0
Revenues
$1,499
Net Income
$88
*Revenues and Net Income are for last twelve months ending 06/30/09
View Prospectus and other SEC Filings

Corporate Data

Company Address
4101 Research Commons, 79 T.W. Alexander Drive
Research Triangle Park, NC
Phone Number
(919) 316-6300
Web Address
www.talecris.com